Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(38%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
8
100%

Phase Distribution

8

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
8(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Recruiting3
Completed2
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 18 (100.0%)

Trials by Status

withdrawn113%
completed225%
recruiting338%
unknown225%

Recent Activity

3 active trials
Showing 5 of 8
recruitingphase_1

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

NCT07111078
completedphase_1

Safety and Immunogenicity of CJCV2 With and Without ALFQ

NCT05500417
recruitingphase_1

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

NCT06863142
recruitingphase_1

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV

NCT06484335
completedphase_1

HIV Vaccine in HIV-uninfected Adults

NCT04658667
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07111078Phase 1

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Recruiting
NCT05500417Phase 1

Safety and Immunogenicity of CJCV2 With and Without ALFQ

Completed
NCT06863142Phase 1

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Recruiting
NCT06484335Phase 1

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV

Recruiting
NCT04658667Phase 1

HIV Vaccine in HIV-uninfected Adults

Completed
NCT05769569Phase 1

Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission

Withdrawn
NCT04268420Phase 1

A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults

Unknown
NCT04296279Phase 1

A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults

Unknown

All 8 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
8